Original Article| Volume 130, ISSUE 5, P515-521, November 2020

Osteonecrosis of the jaw and dental extractions: A single-center experience


      The aim of this study was to investigate the frequency of osteoradionecrosis/medication-related osteonecrosis of the jaw (ORN/MRONJ) after dental extraction with use of postextraction antibiotic coverage without prophylactic hyperbaric oxygen (HBO) in patients who received radiotherapy to head and neck (RT-HN) or antiresorptive medications and to determine possible associated factors.

      Study Design

      A retrospective study was conducted in patients who had a history of RT-HN or exposure to antiresorptives and who underwent dental extractions from 2003 to 2019. According to the clinical protocol, patients received amoxicillin 500 mg, 3 times daily (TID) for at least 14 days, and chlorhexidine 0.12% rinses, 2 times daily (BID), after extraction (or an alternative antibiotic if allergic to amoxicillin). HBO was not used for patients with RT-HN.


      Ninety patients underwent a total of 243 extractions. Fifty patients (55.5%) received a median of 54.1 Gray to the extraction site and 40 (44.4%) were on antiresorptives. None of the patients received both RT and antiresorptives. Of 40 patients, 3 (7.5%) developed MRONJ, and of 50 patients, 1 (2%) developed ORN. Among those at risk for MRONJ, male gender and concomitant immunosuppressant medications were associated with MRONJ development (P < .05).


      In our patient cohort, the rate of postextraction ORN/MRONJ was lower and comparable with the rates reported in the literature. Larger prospective studies are required to validate the efficacy of postextraction antibiotics in reducing ONJ.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Marx RE
        Osteoradionecrosis: a new concept of its pathophysiology.
        J Oral Maxillofac Surg. 1983; 41: 283-288
        • Ruggiero SL
        • Dodson TB
        • Fantasia J
        • Goodday R
        • Aghaloo T
        • Mehrotra B
        O'Ryan F; American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update.
        J Oral Maxillofac Surg. 2014; 72: 1938-1956
        • Hansen T
        • Kunkel M
        • Weber A
        • James Kirkpatrick C
        Osteonecrosis of the jaws in patients treated with bisphosphonates—histomorphologic analysis in comparison with infected osteoradionecrosis.
        J Oral Pathol Med. 2006; 35: 155-160
        • Kanatas AN
        • Rogers SN
        • Martin MV
        A survey of antibiotic prescribing by maxillofacial consultants for dental extractions following radiotherapy to the oral cavity.
        Br Dent J. 2002; 192: 157-160
        • Nabil S
        • Samman N.
        Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review.
        Int J Oral Maxillofac Surg. 2011; 40: 229-243
        • Wahl MJ
        Osteoradionecrosis prevention myths.
        Int J Radiat Oncol Biol Phys. 2006; 64: 661-669
        • Schweiger JW.
        Oral complications following radiation therapy: a five-year retrospective report.
        J Prosthet Dent. 1987; 58: 78-82
        • Epstein JB
        • Rea G
        • Wong FLW
        • Spinelli J
        • Stevenson‐Moore P
        Osteonecrosis: study of the relationship of dental extractions in patients receiving radiotherapy.
        Head Neck Surg. 1987; 10: 48-54
        • Németh Z.
        Possibilities of preventing osteoradionecrosis during complex therapy of tumors of the oral cavity.
        Pathol Oncol Res. 2000; 6: 53-58
        • Bermúdez-Bejarano EB
        • Ángeles SM
        • Gutiérrez-Corrales A
        • et al.
        Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates.
        J Clin Exp Dent. 2017; 9: e141-e149
        • Sultan A
        • Hanna GJ
        • Margalit DN
        • et al.
        The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: a Dana‐Farber/Brigham and Women's Cancer Center multidisciplinary guideline.
        Oncologist. 2017; 22: 343-350
        • Nabil S
        • Samman N.
        Risk factors for osteoradionecrosis after head and neck radiation: a systematic review.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 40: 229-243
        • Thorn JJ
        • Hansen HS
        • Specht L
        • Bastholt L
        Osteoradionecrosis of the jaws: Clinical characteristics and relation to the field of irradiation.
        J Oral Maxillofac Surg. 2000; 58: 1088-1093
        • Chronopoulos A
        • Zarra T
        • Tröltzsch M
        • Mahaini S
        • Ehrenfeld M
        • Otto S
        Osteoradionecrosis of the mandible: a ten year single-center retrospective study.
        J Craniomaxillofac Surg. 2015; 43: 837-846
        • Sivolella S
        • Lumachi F
        • Stellini E
        • Favero L
        Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease.
        Anticancer Res. 2013; 33: 1793-1797
        • Henry DH
        • Costa L
        • Goldwasser F
        • et al.
        Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.
        J Clin Oncol. 2011; 29: 1125-1132
        • Owosho AA
        • Liang STY
        • Sax AZ
        • et al.
        Medication-related osteonecrosis of the jaw: an update on the Memorial Sloan Kettering Cancer Center experience and the role of premedication dental evaluation in prevention.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2018; 125: 440-445
        • Richardson PG
        • Xie W
        • Jagannath S
        • et al.
        A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma.
        Blood. 2014; 123: 1461-1469
        • Ndibe C
        • Wang CG
        • Sonpavde G
        Corticosteroids in the management of prostate cancer: a critical review.
        Curr Treat Options Oncol. 2015; 16: 6
        • Sonis ST
        • Watkins BA
        • Lyng GD
        • Lerman MA
        • Anderson KC
        Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
        Oral Oncol. 2009; 45: 164-172
        • Yamazaki T
        • Yamori M
        • Ishizaki T
        • et al.
        Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study.
        Int J Oral Maxillofac Surg. 2012; 41: 1397-1403
        • Delanian S
        • Lefaix JL.
        The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway.
        Radiother Oncol. 2004; 73: 119-131
        • Meyer I.
        Infectious diseases of the jaws.
        J Oral Surg. 1970; 28: 17-26
        • Støre G
        • Olsen I.
        Scanning and transmission electron microscopy demonstrates bacteria in osteoradionecrosis.
        Int J Oral Maxillofac Surg. 2005; 34: 777-781
        • Tsao C
        • Darby I
        • Ebeling PR
        • et al.
        Oral health risk factors for bisphosphonate-associated jaw osteonecrosis.
        J Oral Maxillofac Surg. 2013; 71: 1360-1366
        • Diniz-Freitas M
        • Limeres J.
        Prevention of medication-related osteonecrosis of the jaws secondary to tooth extractions. A systematic review.
        Med Oral Patol Oral Cir Bucal. 2016; 21: e250-e259
        • Maxymiw WG
        • Wood RE
        • Liu FF
        Postradiation dental extractions without hyperbaric oxygen.
        Oral Surg Oral Med Oral Pathol. 1991; 72: 270-274
        • Lodi G
        • Sardella A
        • Salis A
        • Demarosi F
        • Tarozzi M
        • Carrassi A
        Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series.
        J Oral Maxillofac Surg. 2010; 68: 107-110
        • Nicolatou-Galitis O
        • Schiødt M
        • Mendes RA
        • et al.
        Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2019; 127: 117-135
        • Beumer J
        • Curtis T
        • Harrison RE
        Radiation therapy of the oral cavity: sequelae and management, part 2.
        Head Neck Surg. 1979; 1: 392-408